This invention relates to compounds of the formula
wherein B, X, Y, Z, R
1
and R
2
are as defined in the description, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are modulated by ACCβ inhibitors.
本发明涉及以下公式的化合物,其中B、X、Y、Z、R1和R2如描述中定义,并其药用盐。本发明还涉及含有这些化合物的药物组合物,以及用于治疗和/或预防由ACCβ
抑制剂调节的疾病的方法。